Display options
Cite
Fehniger J, Brodsky AL, Kim A, et al. Medical marijuana utilization in gynecologic cancer patients. Gynecol Oncol Rep. 2021;37:100820doi: 10.1016/j.gore.2021.100820.
Fehniger, J., Brodsky, A. L., Kim, A., & Pothuri, B. (2021). Medical marijuana utilization in gynecologic cancer patients. Gynecologic oncology reports, 37100820. https://doi.org/10.1016/j.gore.2021.100820
Fehniger, Julia, et al. "Medical marijuana utilization in gynecologic cancer patients." Gynecologic oncology reports vol. 37 (2021): 100820. doi: https://doi.org/10.1016/j.gore.2021.100820
Fehniger J, Brodsky AL, Kim A, Pothuri B. Medical marijuana utilization in gynecologic cancer patients. Gynecol Oncol Rep. 2021 Jun 24;37:100820. doi: 10.1016/j.gore.2021.100820. eCollection 2021 Aug. PMID: 34258360; PMCID: PMC8255178.
Copy Download .nbib Format: NLM
Share it on

Gynecol Oncol Rep. 2021 Jun 24;37:100820. doi: 10.1016/j.gore.2021.100820. eCollection 2021 Aug.

Medical marijuana utilization in gynecologic cancer patients.

Gynecologic oncology reports

Julia Fehniger, Allison L Brodsky, Arum Kim, Bhavana Pothuri

Affiliations

  1. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Perlmutter Cancer Center, NYU Langone Health, New York, NY, United States.
  2. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, State University of New York Downstate Health Sciences University, Brooklyn, NY, United States.
  3. Department of Medicine, Division of Geriatric Medicine and Palliative Care, New York University Grossman School of Medicine, New York, NY, United States.

PMID: 34258360 PMCID: PMC8255178 DOI: 10.1016/j.gore.2021.100820

Abstract

BACKGROUND: Medical marijuana (MM) use is common among cancer patients, but relatively little is known about the usage patterns and efficacy of MM used by gynecologic cancer patients.

METHODS: Demographic and clinical data were collected for gynecologic cancer patients prescribed MM between May 2016 and February 2019. The electronic medical record was used to query formulation prescribed, usage patterns, length of use, symptom relief, and side effect profile. Descriptive statistics were calculated.

RESULTS: Of 45 gynecologic cancer patients prescribed MM, 89% were receiving chemotherapy; 56% were undergoing primary treatment. MM was used for a median of 5.2 months (range 0.6-25.4). Over 70% of patients reported improvement in nausea/vomiting, compared to 36% of patients using MM for pain relief (p = 0.02). Of 41 patients with follow-up information, 71% found MM improved at least one symptom.

CONCLUSIONS: Among a small sample of gynecologic cancer patients prescribed MM for symptom management, self-reported follow-up indicated symptom relief for the majority of patients and minimal therapy-related side effects. This data can prove useful for counseling gynecologic cancer patients on the efficacy and side effects of MM.

© 2021 The Authors.

Keywords: Cannabis; Gynecologic cancer; Management of treatment-related toxicity; Medical marijuana; Symptom control

Conflict of interest statement

Julia Fehniger, Allison Brodsky, and Arum Kim have nothing to disclose. Bhavana Pothuri reports grants, personal feels and non-financial support outside the submitted work; institutional PI for indust

References

  1. Med Oncol Tumor Pharmacother. 1986;3(1):39-42 - PubMed
  2. N Engl J Med. 1979 Jun 7;300(23):1295-7 - PubMed
  3. J Clin Oncol. 2018 Jul 1;36(19):1957-1962 - PubMed
  4. J Clin Oncol. 2017 Oct 1;35(28):3240-3261 - PubMed
  5. J Pain Symptom Manage. 2018 Feb;55(2):179-188.e1 - PubMed
  6. Gynecol Oncol. 2020 May;157(2):307-311 - PubMed
  7. Gynecol Oncol Rep. 2019 Sep 09;30:100497 - PubMed
  8. J Pain Symptom Manage. 1991 Aug;6(6):352-9 - PubMed
  9. JAMA. 2015 Jun 23-30;313(24):2456-73 - PubMed
  10. Ann Palliat Med. 2017 Dec;6(Suppl 2):S209-S214 - PubMed
  11. J Pain. 2012 May;13(5):438-49 - PubMed
  12. J Pain Symptom Manage. 2010 Feb;39(2):167-79 - PubMed
  13. Gynecol Oncol Rep. 2020 Nov 02;34:100667 - PubMed
  14. J Pain Symptom Manage. 2014 Jan;47(1):166-73 - PubMed
  15. Br J Pain. 2017 Aug;11(3):119-133 - PubMed
  16. Br J Pharmacol. 2017 Sep;174(17):2832-2841 - PubMed
  17. Cancer. 2019 Jul 1;125(13):2242-2251 - PubMed
  18. Curr Med Res Opin. 2007 Mar;23(3):533-43 - PubMed
  19. J Pain Symptom Manage. 2019 Jun;57(6):e1-e4 - PubMed

Publication Types